More Europeans back biotech

Survey shows EU citizens support stem cell research, but are still very negative about GM foods

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
European citizens are becoming more optimistic about most forms of biotechnology, including embryonic stem cell research, but still can?t be swayed from their distrust of genetically modified food, the latest Eurobarometer survey showed last week.The survey of 25,000 people revealed a surge in positive responses for medical and industrial biotech relative to 2002, but concluded that widespread opposition to agricultural biotechnology remained in all but a few countries.?Overall, Europeans think GM food should not be encouraged,? George Gaskell from the London School of Economics and his colleagues wrote in the report to the European Commission. ?GM food is widely seen as not being useful, as morally unacceptable, and as a risk for society.?The survey showed that stem cell research was widely supported across Europe. Even embryonic stem cell research was supported by 59% of respondents.As things stand, European Union law permits embryonic stem cell research, but leaves it up to each individual member country to make its own policy about whether it should be allowed. Providing there is some level of regulation, an absolute majority of respondents in 15 of the EU?s 25 countries approved of embryonic stem cell use, the report showed. The main religious denomination of the country didn?t appear to be a decisive factor in shaping attitudes, Gaskell and colleagues note. In Germany, where scientists are not allowed to create embryos to derive cells, or collaborate with anyone doing so, 54% of respondents said they approved of the technology, although some said it should be tightly controlled.In Italy, a total of 66% of respondents were in favor of embryonic stem cell research. The country has long had one of Europe?s most stringent rules on embryo research, but in recent weeks the research minister Fabio Mussi suggested allowing such research might not be out of the question in the future. Karim Nayernia, a German stem cell researcher who last week moved to the UK?s Newcastle University to conduct his research, said the findings reflect the views of many Germans that he has spoken to. ?Most of them think that it?s OK -- with some regulation, of course,? he told The Scientist. Oliver Brustle from the University of Bonn said he hoped that politicians would heed these results. ?Governments have to listen to the majority opinion in their countries, to make this field? less restrictive, he said. ?At the least they should establish a framework within which collaboration between European laboratories is easier.?On other topics, the European Union survey shows that the general public is largely supportive of developments in nanotechnology. EU citizens were also widely supportive of pharmacogenetics and gene therapy.Among those who have made their mind up on GM food, 58% were opposed and 17% thought the technology was risky but useful, while 25% thought it should be encouraged and was not risky.Adeline Farrelly, spokeswoman for industry group EuropaBio, noted that overall, the survey was positive for the biotech industry. Agricultural biotech may be less popular, she suggested, because consumers could not see benefits for themselves. ?In surveys like this there are a lot of nuances around the answers people give,? she told The Scientist. ?People seem to identify less with the benefits of GM foods compared with the other technologies.?The report?s authors point out that Europeans are generally as optimistic as their peers in the US when it comes to technology. ?It is invalid to claim that European public opinion is a constraint to technological innovation,? they argue. Farrelly agreed. ?Europeans are not actually technophobes as some people have said in the past,? she noted. Stephen Pincock spincock@the-scientist.comLinks within this articleEuropeans and Biotechnology in 2005 http://www.ec.europa.eu/research/press/2006/pdf/pr1906_eb_64_3_final_report-may2006_en.pdfEuropeans and Biotechnology in 2002 http://www.oeaw.ac.at/ita/ebene5/HT_1176.pdfGeorge Gaskell http://www.lse.ac.uk/people/g.gaskell@lse.ac.uk/S. Pincock, ?EU parliament backs embryo research,? The Scientist, June 16, 2006. http://www.the-scientist.com/news/display/23670/N. Stafford, ?Germany drafts stem cell plan,? The Scientist, May 26, 2005. http://www.the-scientist.com/article/display/22688/Open Letter to President Romano Prodi from European Consortium for Stem Cell Research http://www.eurostemcell.org/Documents/News/OpenLetter_RomanoProdi.pdfEuropaBio http://www.europabio.org/N. Stafford, ?New Swiss GM ban,? The Scientist, December 1, 2005. http://www.the-scientist.com/article/display/22847/
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Stephen Pincock

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio